SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
7680526570169
CH-52657
L04AD01
07.15.0.
Reimbursement limitations:
SANDIMMUN NE
Transplantations.
Maladies immunologiques graves ainsi que rares (aussi celles enregistrées sous Possibilité d'emploi), ne répondant …
1 / 3
google
Details
- Product number
- 5265701
- CPT
- -
- Packaging group
- 50
- Unit
- ml
- Composition
- ciclosporinum 100 mg, ethanolum anhydricum 94.7 mg, propylenglycolum 94.7 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 383.7 mg, E 307, ad solutionem pro 1 ml corresp. ethanolum 12 % V/V.
Articles (1)
Sandimmun Neoral, Trinklösung
Trinklösung
50
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
94.7 MG | Substance | HBESI |
|
(N/A)
|
94.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
383.7 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTOX |
Reimbursement information
Public price
CHF 205.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1995
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 52657
- Drug name
- Sandimmun Neoral, Trinklösung
- Galenic form
- LSOR
- ATC Code
- L04AD01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/05/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
- Description (DE)
- SANDIMMUN NEORAL Trink Lös 100 mg/ml 50 ml
- Market launch
- 16/05/1994
- Narcotic (BTM)
- No